Abstract
We performed secondary analyses of a postdischarge decolonization trial of MRSA carriers that reduced MRSA infection and hospitalization by 30%. Hospitalized MRSA infection was associated with 7.9 days of non-MRSA antibiotics and CDI in 3.9%. Preventing MRSA infection and associated hospitalization may reduce antibiotic use and CDI incidence.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aftercare
-
Anti-Bacterial Agents / therapeutic use
-
Clostridium Infections* / drug therapy
-
Clostridium Infections* / epidemiology
-
Clostridium Infections* / prevention & control
-
Cross Infection* / drug therapy
-
Cross Infection* / epidemiology
-
Cross Infection* / prevention & control
-
Humans
-
Methicillin-Resistant Staphylococcus aureus*
-
Patient Discharge
-
Staphylococcal Infections* / drug therapy
-
Staphylococcal Infections* / epidemiology
-
Staphylococcal Infections* / prevention & control